Welcome : Guest

Ascendis Pharma A/S (Denmark) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Ascendis Pharma A/S, which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 61 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63769
Price: $3050
Company Type: Public
Pages: 63
Date: November 2016
Market Data Tables: 61

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Ascendis Pharma A/S’s Sales by Geographic Region Worldwide (2015) in Percentage for USA, Germany, and Switzerland......2
Hormone Therapy......4
Table 2: Hormone Therapy Treatment Market by Specialist Type Worldwide (2015) - Percentage Share Breakdown by Value for Oncologists, Urologists and Others......4
Table 3: Female Hormone Treatment Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Hormone Replacement Therapy and Others......5
Table 4: Female Hormone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Estrogen, Hormone Replacement Therapy and Vegetable Female Hormone......6
Table 5: Female Hormone Treatment Market by Product in Korea (2015) - Percentage Share Breakdown by Value for Natural Estrogen Therapy and Others......7
Growth Hormones......8
Table 6: Growth Hormone Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......8
Table 7: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......9
Table 8: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......10
Table 9: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......11
Human Growth Hormones (hGH)......12
Table 10: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......12
Table 11: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......13
Pediatric Growth Hormone Deficiency (GHD)......14
Table 12: Pediatric Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......14
Table 13: Pediatric Growth Hormone Deficiency (GHD) Market by Product in the US (2015) - Percentage Share Breakdown by Value Genotropin, Humatrope, Norditropin and FlexPro (NordiFlex), Nutropin AQ and Others......15
Adult Growth Hormone Deficiency (GHD)......16
Table 14: Adult Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe and United States......16
Pulmonary Arterial Hypertension (PAH)......17
Table 15: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......17
Table 16: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......18
Table 17: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......19
Table 18: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......20
Table 19: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......21
Table 20: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......22
Table 21: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......23
Table 22: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......24
Table 23: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......25
Table 24: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......26
Ophthalmic Drugs......27
Table 25: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......27
Table 26: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......28
Diabetes......29
Table 27: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......29
Table 28: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-Like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......30
Table 29: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......31
Table 30: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......32
Table 31: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......33
Table 32: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......34
Table 33: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......35
Table 34: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......36
Table 35: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......37
Table 36: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......38
Diabetes Drugs......39
Table 37: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......39
Table 38: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......40
Table 39: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......41
Table 40: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......42
Table 41: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......43
Table 42: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......44
Table 43: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......45
Table 44: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......46
Table 45: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......47
Table 46: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......48
Table 47: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......49
Non-Insulin Anti-Diabetic Drugs......50
Table 48: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......50
Diabetic Macular Edema (DME)......51
Table 49: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......51
Table 50: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......52
Human Growth Hormones (HGH)......53
Table 51: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......53
Table 52: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......54
Table 53: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......55
Ophthalmology Drugs......56
Table 54: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......56
Table 55: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......57
Table 56: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......58
Table 57: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......59
Table 58: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......60
Age-Related Macular Degeneration......61
Table 59: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......61
Table 60: Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Avastin, Eylea, and Lucentis......62
Table 61: Ascendis Pharma A/S’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for USA and Germany......63